Results 241 to 250 of about 5,456,142 (288)

Mortality trends in diabetes with proxy-defined steatotic liver disease in the United States, 1999-2023. [PDF]

Front Endocrinol (Lausanne)
Liu H, Wang R, Cui L, Wang L, Liu J, Du Y, Dong S, Xia K.   +7 more
europepmc   +1 more source

Prevalence of Metabolic-Dysfunction-Associated Steatotic Liver Disease in Patients with Psoriasis and Psoriatic Arthritis. [PDF]

Diagnostics (Basel)
Vegas-Revenga N, San Juan López C, Sampedro Andrada B, Morillo Montañés V, Urionaguena-Onaindia I, Plaza-Aulestia N, Pérez Prado S, Calvo Zorrilla I, Ibarguengoitia-Barrena O, Montero Seisdedos D, Ibarrola-Paino L, Vega-Álvarez L, Orive Calzada A, Garcia Llorente JF.   +13 more
europepmc   +1 more source

Prevalence and Correlates of Steatotic Liver Disease Among People With HIV in Uganda. [PDF]

Open Forum Infect Dis
Bibangambah P, Acan M, Ghoshhajra B, Erem G, Nassanga R, Ochieng A, Thondapu V, Lu MT, Randhawa M, Takigami A, Reynolds Z, Atwiine F, Tindimwebwa E, Gilbert RF, Hoepner SS, Passell E, Sagar S, Tong Y, Ntusi NAB, Hahn J, Gaziano T, Longenecker CT, Tsai AC, Manne-Goehler JM, Asiimwe S, Okello S, Siedner MJ.   +26 more
europepmc   +1 more source

The Role of Insulin Resistance in Mediating the Association Between Proinflammatory Diets and Metabolic Dysfunction-Associated Steatotic Liver Disease. [PDF]

Food Sci Nutr
Tan Z, He H, Meng Y, Pu Y, Wu Y, Zhang J, Dong W.   +6 more
europepmc   +1 more source

Screening for advanced steatotic liver disease

The Lancet Gastroenterology & Hepatology
Steatotic liver disease often progresses asymptomatically, with the risk of advancing to cirrhosis and liver cancer. Early detection of advanced liver disease through screening presents an opportunity to prevent severe outcomes, if said screening is linked to effective intervention.
Johansen, Stine; id_orcid 0000-0002-5031-2294, Åberg, Fredrik, Tsochatzis, Emmanouil, Krag, Aleksander; id_orcid 0000-0002-9598-4932   +3 more
core   +7 more sources

Steatotic liver disease after pediatric liver transplantation

Liver Transplantation
Metabolic dysfunction–associated steatotic liver disease is becoming an increasingly frequent cause of chronic liver disease in children. It has been reported as a complication of liver transplantation in adults but remains poorly evaluated in liver-transplanted children.
Wischlen, Emma, Boillot, Olivier, Rivet, Christine, Lachaux, Alain, Bouvier, Raymonde, Hervieu, Valérie, Scoazec, Jean-Yves, Collardeau-Frachon, Sophie, Dumortier, Jérôme, Laverdure, Noémie   +9 more
openaire   +3 more sources

Steatotic liver disease and HIV: an agenda for 2030 [PDF]

The Lancet HIV
People living with HIV are particularly susceptible to developing metabolic disorders, including metabolic dysfunction-associated steatotic liver disease and other forms of SLD. However, people living with HIV have been historically excluded from clinical trials and large cohort studies of SLD.
Pericàs, Juan M, Arora, Anish K, Riebensahm, Carlotta, Jiménez-Masip, Alba, Ramírez Mena, Adrià, White, Trenton M, Dedes, Nikos, Guaraldi, Giovanni, Berzigotti, Annalisa, Wandeler, Gilles, Bansal, Meena B, Navarro, Jordi, Lazarus, Jeffrey V   +12 more
openaire   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Chronic Hepatitis C Related Steatotic Liver Disease Is More Than “Miscellaneous Steatotic Liver Disease”

Clinical Gastroenterology and Hepatology
The terminology and definition of fatty liver disease has evolved significantly. Recently, the overarching term of steatotic liver disease (SLD) has been endorsed by international societies.1,2 SLD further encompasses individuals with cardiometabolic risk factors (CMRFs), namely, metabolic dysfunction-associated steatotic liver disease (MASLD).
Ming-Lung Yu, Jee-Fu Huang, Chung-Feng Huang   +2 more
exaly   +3 more sources